This was 1 year ago
LocationNCBR Office, Belliardstraat 40, 1040 Brussels
ProgrammesBiodiversity is fundamental to healthy ecosystems and life on our planet. However, biodiversity is being lost at an unprecedented rate, threatening our global economic and human wellbeing. Circular economy can help us to halt and reverse biodiversity loss and support conservation efforts to bend the curve towards a nature-positive future. The event will focus on the research and innovation communities of Cyprus, Greece, Lithuania, Poland, Slovenia and Hungary, as well as other relevant European stakeholders in order to display their strengths and ideas for future consortia in Horizon Europe calls, with a particular focus on biodiversity and circular economy (Cluster 6).
Researchers, businesses and other organizations are invited to pitch their project ideas or activities, related to the Horizon Europe Cluster 6 calls. Please see the calls for proposals for the Cluster 6 on biodiversity and circular economy HERE.
You can either register as an attendee (you will have the opportunity to listen to the pitches) or as a pitch presenter (to present a 5-minute pitch of your ideas and activities). We encourage you to have only 1 pitch presentation per institution. As there is a limited number of pitch presentations, the organisers reserve the right to select presenters. Presenters will receive more detailed information about the expected structure and content of their pitches after their registration.
The deadline for registration and for the submission of pitch presentations is Friday, 26 May 2023.
The detailed programme is available here, because of limited space available, we urge you to register here ASAP.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.